UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.

Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients.

The Department of Global Health recently awarded its 2020 Outstanding Staff Award to Noura Youssoufa (Academic Advisor, MPH and Undergraduate Programs). Her role as Academic Advisor includes working with prospective MPH students – both in-person, online, and at conference recruitment events – as well as organizing Visit Days for all admitted graduate students in the department.

The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April

Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.

A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC)  in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.

Jennifer Velloza spent a year crisscrossing the grass-covered plains and sloping hills of rural Swaziland, dividing her time among ten medical clinics in this small southern African country. Here, nearly one in four people have HIV — and that rate is even higher among women.

As a study manager for Doctors Without Borders, Velloza saw many pregnant and postpartum women struggle to get the HIV testing and treatment they needed, because they were also suffering from sexual trauma, depression or anxiety.